Skip to main content

Navigation group

Type at least 3 characters
422 articles

Articles

Original Research

Published on 20 Apr 2021

Fibroblast Growth Factor Type 2 (FGF2) Administration Attenuated the Clinical Manifestations of Preeclampsia in a Murine Model Induced by L-NAME

in Obstetric and Pediatric Pharmacology

  • Margarita L Martinez-Fierro
  • Gloria Patricia Hernadez-Delgadillo
  • Jose Feliciano Flores-Mendoza
  • Claudia Daniela Alvarez-Zuñiga
  • Martha Lizeth Diaz-Lozano
  • Ivan Delgado-Enciso
  • Viktor Javier Romero-Diaz
  • Adrian Lopez-Saucedo
  • Iram Pablo Rodriguez-Sanchez
  • Ivan Alberto Marino-Martinez
Fibroblast Growth Factor Type 2 (FGF2) Administration Attenuated the Clinical Manifestations of Preeclampsia in a Murine Model Induced by L-NAME
Frontiers in Pharmacology
doi 10.3389/fphar.2021.663044
  • 3,838 views
  • 11 citations